Showing results (441-450 of 760) with videos related to

Sort By:
Pageof 76
Cancer Immunology, Immunotherapy : CII|June 27, 2012
Lenalidomide enhances anti-myeloma cellular immunityKatarina Luptakova, Jacalyn Rosenblatt, Brett Glotzbecker, et al.
Bone|January 22, 2013
In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myelomaSamantha Pozzi, Mariateresa Fulciniti, Hua Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2014
Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapyChirayu G Patel, Andrew J Yee, Tyler A Scullen, et al.
Haematologica|September 28, 2014
Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myelomaMeletios A Dimopoulos, Robert Z Orlowski, Thierry Facon, et al.
Molecular Cancer Therapeutics|August 31, 2014
Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor, AZD8055, in multiple myelomaDiana Cirstea, Loredana Santo, Teru Hideshima, et al.
Cancer Research|April 17, 2004
Mechanisms by which SGN-40, a humanized anti-CD40 antibody, induces cytotoxicity in human multiple myeloma cells: clinical implicationsYu-Tzu Tai, Laurence P Catley, Constantine S Mitsiades, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Generation of antitumor invariant natural killer T cell lines in multiple myeloma and promotion of their functions via lenalidomide: a strategy for immunotherapyWeihua Song, Hans J J van der Vliet, Yu-Tzu Tai, et al.
Blood Advances|July 26, 2022
Improving NK cell function in multiple myeloma with NKTR-255, a novel polymer-conjugated human IL-15Rafael Alonso Fernandez, Jessica Encinas Mayoral, Laetitia Pierre-Louis, et al.
British Journal of Haematology|September 16, 2009
In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465Joseph M Negri, Douglas W McMillin, Jake Delmore, et al.
Cancer Research|October 3, 2003
Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3'-kinase/AKT signalingYu-Tzu Tai, Klaus Podar, Laurence Catley, et al.
Pageof 76